Pathologic considerations in the high-risk breast patient.
An understanding of the spectrum of benign breast changes is necessary to optimize diagnosis and treatment. To evaluate the relative risk for developing cancer with benign breast lesions, each of the entities included in the category of benign breast conditions is discussed individually.
Simmons
R
R
Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Serafin
D
D
McCarty
K
K
D000232:Adenofibroma / Q000473:pathology; D001940:Breast / Q000473:pathology; D001941:Breast Diseases / Q000150:complications / Q000473:pathology*; D001943:Breast Neoplasms / Q000209:etiology / Q000473:pathology; D002278:Carcinoma in Situ / Q000473:pathology; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000473:pathology; D005260:Female; D005348:Fibrocystic Breast Disease / Q000473:pathology; D006801:Humans; D012307:Risk Factors